Meredith Wadman
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 5%
Papers in
-
- Science, Research, and Medicine 197
-
- Health and Medical Research Impacts 81
- Biotechnology and Related Fields 64
- Ethics in Clinical Research 19
- Co-authors
- Kai Kupferschmidt (2 shared papers)Jocelyn Kaiser (5 shared papers)Jennifer Couzin-Frankel (1 shared paper)Declan Butler (4 shared papers)Alison Abbott (1 shared paper)Jim Giles (1 shared paper)Eric Hand (2 shared papers)Olle Ekberg (1 shared paper)
- Journals
- Nature (320 papers)Science (147 papers)Nature Medicine (29 papers)Nature Reviews Drug Discovery (4 papers)Nature Biotechnology (2 papers)
- Partner nations
- United StatesNetherlandsIreland
In The Last Decade
Meredith Wadman
448 papers receiving 2.2k citations
Meredith Wadman's Hit Papers
Peers
Comparison fields: 5 of 198
- Infectious Diseases 361
- Modeling and Simulation 76
- Health 119
- Reproductive Medicine 100
- Public Health, Environmental and Occupational Health 331
Countries citing papers authored by Meredith Wadman
This map shows the geographic impact of Meredith Wadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith Wadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith Wadman more than expected).
Fields of papers citing papers by Meredith Wadman
This network shows the impact of papers produced by Meredith Wadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith Wadman. The network helps show where Meredith Wadman may publish in the future.
Co-authors
The 25 scholars most cited alongside Meredith Wadman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 512 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA no longer has to require animal testing for new drugs Hit paper breakdown → | 2023 | 249 |
| 2 | 2020 | 165 | |
| 3 | 2021 | 103 | |
| 4 | 2020 | 54 | |
| 5 | 2013 | 50 | |
| 6 | 2006 | 46 | |
| 7 | 2005 | 35 | |
| 8 | 2012 | 29 | |
| 9 | 2021 | 27 | |
| 10 | 2020 | 25 | |
| 11 | 2008 | 24 | |
| 12 | 2021 | 22 | |
| 13 | 2007 | 21 | |
| 14 | 2019 | 20 | |
| 15 | 2017 | 20 | |
| 16 | 2023 | 19 | |
| 17 | 2005 | 18 | |
| 18 | 1999 | 18 | |
| 19 | 2020 | 16 | |
| 20 | 2020 | 16 |
About Meredith Wadman
Meredith Wadman is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health, Physiology, Molecular Biology and Economics and Econometrics, having authored 512 papers that have together received 2.4k indexed citations. Recurring topics across this work include Science, Research, and Medicine (197 papers), Biomedical Ethics and Regulation (97 papers), Health and Medical Research Impacts (81 papers), Biotechnology and Related Fields (64 papers), Pharmaceutical Economics and Policy (20 papers), Ethics in Clinical Research (19 papers), Biomedical and Engineering Education (16 papers) and Pharmaceutical industry and healthcare (9 papers). The work is most often cited by research in Infectious Diseases (361 citations), Modeling and Simulation (76 citations), Health (119 citations), Reproductive Medicine (100 citations) and Public Health, Environmental and Occupational Health (331 citations). Meredith Wadman has collaborated with scholars based in United States, Netherlands and Ireland. Frequent co-authors include Kai Kupferschmidt, Jocelyn Kaiser, Jennifer Couzin-Frankel, Declan Butler, Alison Abbott, Jim Giles, Eric Hand, Olle Ekberg, Martin Enserink and Sölve Elmståhl. Their work appears in journals such as Nature, Science, Nature Medicine, Nature Reviews Drug Discovery and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.